The heterozygote state for β-thalassemia detrimentally affects health outcomes

Am J Hematol. 2017 Mar;92(3):E23-E25. doi: 10.1002/ajh.24619. Epub 2017 Feb 1.

Authors

Luciano Graffeo¹, Angela Vitrano¹, Antonino Giambona¹, Salvatore Scondotto², Gabriella Dardanoni², Christian Gluud³, Aurelio Maggio¹

Affiliations

¹ Campus of Hematology Franco e Piera Cutino, AOOR Villa Sofia-V. Cervello, Palermo, Italy.
² Dipartimento Attività Sanitarie e Osservatorio Epidemiologico Assessorato Salute Regione Sicilia, Palermo, Italy.
³ The Copenhagen Trial Unit, Centre for Clinical Intervention Research, Department 7812, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.

PMID: 27935096
DOI: 10.1002/ajh.24619

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Female
Heterozygote*
Humans
Male
Models, Genetic*
beta-Thalassemia / epidemiology*
beta-Thalassemia / genetics*